Session 5: Challenging Situations

Moderator(s)

• 

  Shaf Keshavjee, MD MSc FRCSC FACS

  Chief of Innovation
  University Health Network, University of Toronto
  Toronto, Ontario, Canada

  Disclosure(s): Abbott: Advisory Board (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Lung Bioengineering: Consultant (Ongoing); SQI Diagnostics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 22, 2023); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
• 

  Yoshiya Toyoda, MD, PhD (he/him/his)

  Temple University Hospital
  Philadelphia, Pennsylvania, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 3:50 PM - 4:00 PM CT

  Re-Transplant
  

  Invited Speaker: Duane Davis, MD (he/him/his) – Adventhealth
• 4:00 PM - 4:10 PM CT

  Lobar and Segmental Transplantation Techniques Including Living Related Lung Transplant
  

  Invited Speaker: Hiroshi X. Date, MD, PhD – Kyoto University Graduate School of Medicine
• 4:10 PM - 4:20 PM CT

  COVID ARDS
  

  Invited Speaker: Tiago N. Machuca, MD (he/him/his) – University of Miami
• 4:20 PM - 4:30 PM CT

  Management of Pleural Space Complications
  

  Invited Speaker: Daniel P. McCarthy, MD, MBA – University of Wisconsin